Evaluation of p53, Caspase-3, Bcl-2, and Ki-67 markers in oral squamous cell carcinoma and premalignant epithelium in a sample from Alava Province (Spain)

被引:7
作者
Bascones-Martinez, Antonio [1 ]
Rodriguez-Gutierrez, Carlos [1 ]
Rodriguez-Gomez, Enrique [2 ]
Gil-Montoya, Jose-Antonio [3 ]
Gomez-Font, Rafael [1 ]
Gonzalez-Moles, Miguel-Angel [3 ]
机构
[1] Univ Complutense Madrid, Dept Med & Bucofacial Surg, Sch Dent, E-28040 Madrid, Spain
[2] Hosp Txagorritxu Osakidetza, Vitoria 01006, Alava, Spain
[3] Univ Granada, Sch Dent, Dept Oral Med, E-18071 Granada, Spain
来源
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL | 2013年 / 18卷 / 06期
关键词
Cell cycle; apoptosis; p53; caspase-3; Bcl-2; Ki-67; NECK-CANCER; FIELD CANCERIZATION; HEAD; EXPRESSION; GENE;
D O I
10.4317/medoral.18901
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives: The objective of this study was to determine whether alterations in the expression of p53, caspase-3 Bcl-2, and ki-67 appear early in premalignant oral epithelium and show clonal behavior. Study Design: Samples from 41 tumors with their adjacent non-tumor epithelia were immunohistochemically analyzed using monoclonal antibodies that recognize p53, caspase-3, Bcl-2, and Ki-67 Results: A statistically significant association was found between the expression in tumor and adjacent epithelium of p53, caspase-3, and Bcl-2 but not of k-67. A significant association was observed between the expression of ki-67 and p53 in both localizations. In non-tumor (premalignant) epithelium samples, there was a significant inverse relationship between the expressions of p53 and caspase-3 and a significant direct relationship between the expressions of p53 and Bcl-2. Conclusions: Alterations in these proteins appear to operate in combination with premalignant epithelia to create hyperproliferative cell states that favor the acquisition of summative oncogenic errors that confer invasive capacity.
引用
收藏
页码:E846 / E850
页数:5
相关论文
共 17 条
[1]   Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India [J].
Baral, R ;
Patnaik, S ;
Das, BR .
EUROPEAN JOURNAL OF ORAL SCIENCES, 1998, 106 (05) :907-913
[2]  
Braakhuis BJM, 2003, CANCER RES, V63, P1727
[3]   p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma:: A prospective series [J].
Cabelguenne, A ;
Blons, H ;
de Waziers, I ;
Carnot, F ;
Houllier, AM ;
Soussi, T ;
Brasnu, D ;
Beaune, P ;
Luccourreye, O ;
Laurent-Puig, P .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) :1465-1473
[4]  
Califano J, 1996, CANCER RES, V56, P2488
[5]   Molecular pathogenesis of oral squamous cell carcinoma: Implications for therapy [J].
Choi, S. ;
Myers, J. N. .
JOURNAL OF DENTAL RESEARCH, 2008, 87 (01) :14-32
[6]   The p53 network in head and neck cancer [J].
Gasco, M ;
Crook, T .
ORAL ONCOLOGY, 2003, 39 (03) :222-231
[7]   Analysis of Ki-67 expression in oral squamous cell carcinoma: Why Ki-67 is not a prognostic indicator [J].
Gonzalez-Moles, M. A. ;
Ruiz-Avila, I. ;
Gil-Montoya, J. A. ;
Esteban, F. ;
Bravo, M. .
ORAL ONCOLOGY, 2010, 46 (07) :525-530
[8]   Ki-67 expression in non-tumour epithelium adjacent to oral cancer as risk marker for multiple oral tumours [J].
Gonzalez-Moles, M. A. ;
Bravo, M. ;
Ruiz-Avila, I. ;
Acebal, F. ;
Gil-Montoya, J. A. ;
Brener, S. ;
Esteban, F. .
ORAL DISEASES, 2010, 16 (01) :68-75
[9]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[10]   Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation [J].
Howard, Jason D. ;
Lu, Bo ;
Chung, Christine H. .
ORAL ONCOLOGY, 2012, 48 (01) :10-17